Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Mizar Bio AS
AS
Active
Org 917152004
Storbjørnen 16, 8029
Bodø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 10 years old
4 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Mizar Bio AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 2M (+100% vs 2021)
2M
+100%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 1M (-50% vs 2023)
1M
-50%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
NOK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
681
932
2 170
2 113
1 022
Staff expenses
−102
−434
−1 089
−1 042
−507
EBITDA
370
36
533
592
154
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
370
36
533
592
154
Net financials
−933
0
0
1
2
Profit before tax
−563
36
533
594
155
Tax
81
8
117
58
−0
Net profit
−644
28
416
536
155
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
1 099
1 853
2 159
1 598
870
Equity
974
1 618
1 591
1 175
457
Long-term debt
0
0
0
0
0
Short-term debt
124
235
568
423
413
Total debt
124
235
568
423
413
Financial ratios
5-year trend
EBITDA margin
54,4 %
This company
15,8 %
Market median
This company
Market median
244% above market
2021
2025
Equity ratio
88,7 %
This company
38,2 %
Market median
This company
Market median
132% above market
2021
2025
Return on equity
−66,1 %
This company
18,4 %
Market median
This company
Market median
459% below market
2021
2025
Net profit margin
−94,6 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,62×
This company
1,12×
Market median
This company
Market median
45% below market
2021
2025
Debt / equity
0,13×
This company
0,62×
Market median
This company
Market median
79% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Mizar Bio AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
